(VIANEWS) - Plains All American Pipeline, L.P. (PAA), CubeSmart (CUBE), Regeneron Pharmaceuticals (REGN) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Plains All American Pipeline, L.P. (PAA)
77.2% sales growth and 5.74% return on equity
Plains All American Pipeline, L.P., through its subsidiaries, engages in the transportation, storage, terminalling, and marketing of crude oil, natural gas liquids (NGL), and natural gas in the United States and Canada.
Plains All American Pipeline, L.P.'s sales growth this year is expected to be 5.2% and a negative 3.4% for next year.
Year-on-year quarterly revenue growth grew by 117.8%, now sitting on 42.08B for the twelve trailing months.
Volume
Today's last reported volume for Plains All American Pipeline, L.P. is 4468570 which is 20.8% below its average volume of 5642540.
Plains All American Pipeline, L.P.'s sales growth for the next quarter is 77.2%. The company's growth estimates for the current quarter and the next is 28% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.74%.
Volatility
Plains All American Pipeline, L.P.'s last day, last week, and last month's current intraday variation average was 3.70%, 3.20%, and 1.93%, respectively.
Plains All American Pipeline, L.P.'s highest amplitude of average volatility was 5.39% (day), 5.34% (last week), and 4.00% (last month), respectively.
Plains All American Pipeline, L.P.'s Stock Yearly Top and Bottom Value
Plains All American Pipeline, L.P.'s stock is valued at $10.80 at 06:22 EST, way under its 52-week high of $12.38 and way above its 52-week low of $8.57.
Plains All American Pipeline, L.P.'s Moving Average
Plains All American Pipeline, L.P.'s value is higher than its 50-day moving average of $10.63 and higher than its 200-day moving average of $10.34.2. CubeSmart (CUBE)
25.7% sales growth and 9.07% return on equity
CubeSmart is a self-administered and self-managed real estate investment trust.
CubeSmart's sales growth this year is anticipated to be 22.7% and 4% for next year.
Year-on-year quarterly revenue growth grew by 24.2%, now sitting on 824.94M for the twelve trailing months.
Volume
Today's last reported volume for CubeSmart is 1363050 which is 27.11% below its average volume of 1870060.
CubeSmart's sales growth for the next quarter is 25.7%. The company's growth estimates for the present quarter and the next is 9.5% and 8.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.07%.
CubeSmart's Stock Yearly Top and Bottom Value
CubeSmart's stock is valued at $49.41 at 06:22 EST, way under its 52-week high of $57.34 and way higher than its 52-week low of $36.27.
CubeSmart's Moving Average
CubeSmart's value is below its 50-day moving average of $51.13 and under its 200-day moving average of $50.95.3. Regeneron Pharmaceuticals (REGN)
18.3% sales growth and 51.09% return on equity
Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for treating various medical conditions worldwide.
Regeneron Pharmaceuticals's sales growth this year is anticipated to be 56.3% and a negative 10.8% for next year.
Year-on-year quarterly revenue growth grew by 50.5%, now sitting on 13.36B for the twelve trailing months.
Volume
Today's last reported volume for Regeneron Pharmaceuticals is 396427 which is 45.37% below its average volume of 725783.
Regeneron Pharmaceuticals's sales growth for the next quarter is 18.3%. The company's growth estimates for the present quarter and the next is 7.7% and 8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 51.09%.
Volatility
Regeneron Pharmaceuticals's last day, last week, and last month's current intraday variation average was 1.57%, 2.04%, and 1.62%, respectively.
Regeneron Pharmaceuticals's highest amplitude of average volatility was 2.06% (day), 2.63% (last week), and 2.40% (last month), respectively.
Regeneron Pharmaceuticals's Stock Yearly Top and Bottom Value
Regeneron Pharmaceuticals's stock is valued at $679.76 at 06:22 EST, under its 52-week high of $686.62 and way above its 52-week low of $441.00.
Regeneron Pharmaceuticals's Moving Average
Regeneron Pharmaceuticals's value is way above its 50-day moving average of $610.79 and way above its 200-day moving average of $567.66.Previous days news about Regeneron Pharmaceuticals(REGN)
- According to Benzinga on Monday, 21 March, "Someone with a lot of money to spend has taken a bearish stance on Regeneron Pharmaceuticals REGN.", "Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $320.0 to $760.0 for Regeneron Pharmaceuticals over the last 3 months."
4. ViacomCBS (VIAC)
9.6% sales growth and 17.48% return on equity
ViacomCBS's sales growth this year is expected to be 11.2% and 3.6% for next year.
Year-on-year quarterly revenue growth grew by 13.2%, now sitting on 27.46B for the twelve trailing months.
Volume
Today's last reported volume for ViacomCBS is 87514000 which is 461.24% above its average volume of 15592900.
ViacomCBS's sales growth is a negative 0% for the current quarter and 9.6% for the next. The company's growth estimates for the ongoing quarter and the next is a negative 16.5% and negative -30.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.48%.
Volatility
ViacomCBS's last day, last week, and last month's current intraday variation average was 0.72%, 0.64%, and 1.75%, respectively.
ViacomCBS's highest amplitude of average volatility was 1.69% (day), 2.41% (last week), and 3.87% (last month), respectively.
ViacomCBS's Stock Yearly Top and Bottom Value
ViacomCBS's stock is valued at $29.58 at 06:22 EST, way below its 52-week high of $101.97 and higher than its 52-week low of $28.90.
ViacomCBS's Moving Average
ViacomCBS's worth is way below its 50-day moving average of $35.62 and way below its 200-day moving average of $43.11.5. Gladstone Investment Corporation (GAIN)
8.8% sales growth and 26.23% return on equity
Gladstone Investment Corporation specializes in lower middle market, mature stage, buyouts; refinancing existing debt; senior debt securities such as senior loans, senior term loans, lines of credit, and senior notes; senior subordinated debt securities such as senior subordinated loans and senior subordinated notes; junior subordinated debt securities such as subordinated notes and mezzanine loans; limited liability company interests, and warrants or options.
Gladstone Investment Corporation's sales growth this year is expected to be 23.1% and a negative 4.1% for next year.
Year-on-year quarterly revenue growth declined by 3.6%, now sitting on 70.01M for the twelve trailing months.
Volume
Today's last reported volume for Gladstone Investment Corporation is 167475 which is 34.97% above its average volume of 124083.
Gladstone Investment Corporation's sales growth for the next quarter is 8.8%. The company's growth estimates for the present quarter and the next is 155.6% and 414.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 26.23%.
Volatility
Gladstone Investment Corporation's last day, last week, and last month's current intraday variation average was 2.20%, 1.93%, and 1.67%, respectively.
Gladstone Investment Corporation's highest amplitude of average volatility was 3.16% (day), 2.77% (last week), and 2.94% (last month), respectively.
Gladstone Investment Corporation's Stock Yearly Top and Bottom Value
Gladstone Investment Corporation's stock is valued at $15.82 at 06:22 EST, under its 52-week high of $17.15 and way higher than its 52-week low of $11.75.
Gladstone Investment Corporation's Moving Average
Gladstone Investment Corporation's value is higher than its 50-day moving average of $15.61 and above its 200-day moving average of $15.25.6. Banco Latinoamericano de Comercio Exterior, S.A. (BLX)
8.7% sales growth and 6.18% return on equity
Banco Latinoamericano de Comercio Exterior, S.A., a multinational bank, primarily engages in the financing of foreign trade in Latin America and the Caribbean.
Banco Latinoamericano de Comercio Exterior, S.A.'s sales growth this year is anticipated to be 8.7% and a negative 0% for next year.
Year-on-year quarterly revenue growth grew by 15.9%, now sitting on 101.88M for the twelve trailing months.
Volume
Today's last reported volume for Banco Latinoamericano de Comercio Exterior, S.A. is 11316 which is 90% below its average volume of 113193.
Banco Latinoamericano de Comercio Exterior, S.A.'s sales growth for the next quarter is 8.7%. The company's growth estimates for the present quarter and the next is 34.4% and 27.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.18%.
Volatility
Banco Latinoamericano de Comercio Exterior, S.A.'s last day, last week, and last month's current intraday variation average was 0.87%, 1.06%, and 1.10%, respectively.
Banco Latinoamericano de Comercio Exterior, S.A.'s highest amplitude of average volatility was 2.35% (day), 1.79% (last week), and 2.32% (last month), respectively.
Banco Latinoamericano de Comercio Exterior, S.A.'s Stock Yearly Top and Bottom Value
Banco Latinoamericano de Comercio Exterior, S.A.'s stock is valued at $14.99 at 06:22 EST, way below its 52-week high of $19.33 and higher than its 52-week low of $14.30.
Banco Latinoamericano de Comercio Exterior, S.A.'s Moving Average
Banco Latinoamericano de Comercio Exterior, S.A.'s worth is under its 50-day moving average of $16.24 and below its 200-day moving average of $16.52.7. Medical Properties Trust (MPW)
7.2% sales growth and 8.32% return on equity
Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities.
Medical Properties Trust's sales growth this year is expected to be 7.4% and 7.4% for next year.
Year-on-year quarterly revenue growth grew by 22.8%, now sitting on 1.57B for the twelve trailing months.
Volume
Today's last reported volume for Medical Properties Trust is 5176780 which is 6.06% above its average volume of 4880560.
Medical Properties Trust's sales growth for the next quarter is 7.2%. The company's growth estimates for the ongoing quarter and the next is 10.7% and 57.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.32%.
Volatility
Medical Properties Trust's last day, last week, and last month's current intraday variation average was 2.28%, 0.93%, and 1.30%, respectively.
Medical Properties Trust's highest amplitude of average volatility was 2.88% (day), 2.66% (last week), and 2.70% (last month), respectively.
Medical Properties Trust's Stock Yearly Top and Bottom Value
Medical Properties Trust's stock is valued at $20.15 at 06:22 EST, way under its 52-week high of $24.13 and higher than its 52-week low of $19.39.